3/8/2023 0 Comments Syn stock price![]() shares of the series c and series d preferred stock are convertible at the option of the holder at the earlier of (i) the date of the company's receipt of shareholder approval for an increase to the authorized shares of common stock of the company from 20 million to 350 million and (ii) octo(which may be extended to decemif certain conditions are met). Instantly find out the Synthetic Biologics, Inc. each share of series c and series d preferred stock is convertible into shares of the company's common stock at an initial conversion price of $1.22 per share. Check the real-time SYN stock price on the AMEX exchange and access historical data for Synthetic Biologics, Inc. Our investment research resources are provided to help you make informed. difficile infection, antibiotic-associated diarrhea, and the. Get the latest price and volume on Synthetic Biologics Inc in IBD stock charts. SYN-004 is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. ![]() ROCKVILLE, Md., J(GLOBE NEWSWIRE) - Synthetic Biologics, Inc. Get Theriva Biologics, Inc.s stock price today. each share of series c and series d preferred stock has a purchase price of $8.00. Synthetic Biologics Announces 3 Million Private Placement of Convertible Preferred Stock. (nyse american: syn) (“synthetic biologics” or the “company”), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced the private placement of 275,000 shares of series c convertible preferred stock and 100,000 shares of series d convertible preferred stock. The average Synthetic Biologics stock forecast 2025 represents a -27.62 decrease from the last price of 0.280000001192093. Rockville, md., j(globe newswire) - synthetic biologics, inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |